Olanzapine-induced agranulocytosis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10470705.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The antipsychotic drug olanzapine was developed to reduce the risk of haematotoxicity. We report a case of agranulocytosis induced by olanzapine.
Medical subject headings
- Agranulocytosis
- Antipsychotic Agents
- Pirenzepine
- Schizophrenia